PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor
<p>Pharmaceutical R&D and Life Sciences Veterans Will Advise PhaseV as it Scales AI Platform to Bridge the Gap Between Clinical Development Strategy, Execution and Regulatory Submission BOSTON, Sept. 16, 2026 /PRNewswire/ -- PhaseV, a leader in machine learning for clinical development,...</p>
Read original article ↗
Related Articles
Datasea plans to combine its AI agent and digital platform capabilities with its partner's robotics technologies and eld
Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI
5.1-fold enrichment using NIH Tox21 data validates structure-based AChE screening as OpenAI and Anthropic highlight grow
Informer Apps helps organizations turn business challenges into purpose-built solutions grounded in trusted, governed da